Glaxo continues emerging markets push

GlaxoSmithKline is continuing its investment in emerging markets with the acquisition of Bristol-Myers Squibb Pakistan and certain associated trademarks for some US$36.5 million (£24.6 million)

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses. More by Marc Barber